Tesamorelin vs sermorelin: compare FDA approval, potency, half-life, and off-label use. Learn which GHRH analog may suit different research or clinical goals.
Tesamorelin and sermorelin are both synthetic analogs of growth hormone-releasing hormone (GHRH) that prompt the pituitary gland to release growth hormone. The main difference is that tesamorelin is FDA-approved for HIV-associated lipodystrophy, while sermorelin is not FDA-approved for any human use and is only available off-label. Neither peptide is approved for muscle growth or general weight loss.
What Are Tesamorelin and Sermorelin?
Tesamorelin (brand name Egrifta) is a stabilized GHRH analog approved in the United States to reduce excess visceral abdominal fat in adults with HIV and lipodystrophy. It is given as a daily subcutaneous injection and has been shown in clinical trials to decrease visceral adipose tissue and increase IGF-1 levels.
Sermorelin is a shorter GHRH fragment (GRF 1-29) that was once used in diagnostic testing for pediatric growth hormone deficiency. Today, it is most often prescribed off-label by compounding pharmacies for anti-aging, sleep, and body composition goals. Sermorelin has a shorter half-life than tesamorelin and is not FDA-approved for any indication.
| Feature | Tesamorelin | Sermorelin |
|---|---|---|
| FDA approval | Approved for HIV-associated lipodystrophy (Egrifta) | Not FDA-approved for any indication |
| Mechanism | GHRH analog; binds GHRH receptors | GHRH analog (GRF 1-29); binds GHRH receptors |
| Half-life | Longer (approximately 26–38 minutes) | Shorter (approximately 10–20 minutes) |
| Typical dose | 1.4 mg or 2 mg daily subcutaneous | 100–300 mcg daily subcutaneous (off-label) |
| Primary studied effect | Visceral fat reduction | GH/IGF-1 increase (off-label) |
| Availability | Prescription, brand or generic | Compounded prescription only |
| Cost | Higher | Lower |
| Common side effects | Injection site reactions, joint pain, swelling | Injection site reactions, flushing, headache |
Key Differences Between Tesamorelin and Sermorelin
Although both are GHRH analogs, they are not interchangeable. The table above summarizes the main contrasts, but a few points deserve emphasis. When comparing tesamorelin peptide vs sermorelin, the most important factor is regulatory status.
- FDA approval: Tesamorelin is the only GHRH analog approved for a clinical indication in the US. Sermorelin is not FDA-approved and is sold through compounding pharmacies, which means quality and purity can vary.
- Potency and half-life: Tesamorelin is more potent and longer-acting than sermorelin. This means it produces a stronger, more sustained increase in IGF-1.
- Cost: Tesamorelin is significantly more expensive. Sermorelin is cheaper but often not covered by insurance because it is off-label.
- Legal status: Tesamorelin is a prescription drug. Sermorelin is a compounded peptide, and its legal status for human use is less clear.
Dosing and Administration
Tesamorelin is typically injected once daily at a dose of 1.4 mg or 2 mg, depending on the formulation. Sermorelin is usually dosed at 100–300 mcg daily, often at bedtime to mimic natural GH release. Both require subcutaneous injection and rotation of injection sites.
Tesamorelin vs Sermorelin for Muscle Growth
Neither tesamorelin nor sermorelin is a muscle-building drug. They increase growth hormone and IGF-1, which can influence lean mass, but the effect is modest compared to anabolic steroids. Clinical trials of tesamorelin focused on visceral fat reduction, not muscle hypertrophy. Sermorelin lacks large randomized trials for muscle growth.
The phrase tesamorelin vs sermorelin for muscle growth is a common search, but anecdotal reports on forums like Reddit describe improved recovery and slight body composition changes. These reports are not substitutes for clinical evidence. If your goal is muscle growth, growth hormone secretagogues are generally not the most effective option.
For broader comparisons, researchers often look at tesamorelin vs sermorelin vs ipamorelin or sermorelin vs tesamorelin to understand how different secretagogues stack up.
Side Effects and Safety
Both peptides can cause injection site reactions, joint pain, swelling, and changes in blood sugar. Tesamorelin has a boxed warning for increased risk of malignancy and diabetes, and it can cause fluid retention. Sermorelin's side effect profile is less well-studied because it lacks FDA approval.
Long-term safety data for sermorelin are limited. Anyone considering these peptides should consult a healthcare professional. They are not approved for general anti-aging or athletic use.
Which Is Better: Tesamorelin or Sermorelin?
Which is better depends on the goal and legal context. Tesamorelin is the only FDA-approved option, with proven efficacy for visceral fat in HIV-associated lipodystrophy. Sermorelin is cheaper and more accessible off-label but lacks regulatory approval and robust clinical data. Choosing between sermorelin or tesamorelin often comes down to cost and access.
For most people, neither peptide is a first-line treatment for weight loss or muscle gain. A doctor can help weigh the risks and benefits.
Other Peptides to Compare
Tesamorelin and sermorelin are part of a larger class of growth hormone secretagogues. Related compounds include CJC-1295, ipamorelin, and AOD-9604. A common comparison is tesamorelin vs sermorelin vs cjc-1295, which looks at half-life and potency. Another is aod-9604 peptide vs tesamorelin, especially for fat-loss research.
These peptides are not approved for general weight loss or athletic performance. Always consult a healthcare professional before using any peptide.
Frequently Asked Questions
Is tesamorelin and sermorelin the same?
No, they are different peptides. Tesamorelin is FDA-approved for HIV-associated lipodystrophy, while sermorelin is not FDA-approved for any indication and is used off-label. They both stimulate growth hormone release, but they have different potencies and half-lives.
Which is better, tesamorelin or sermorelin?
Tesamorelin is better studied and FDA-approved for a specific condition, but it is more expensive and requires a prescription. Sermorelin is cheaper and more accessible off-label, but it lacks regulatory approval and robust clinical data. The better choice depends on your goals and medical guidance.
Can tesamorelin or sermorelin help with weight loss?
Tesamorelin is approved to reduce visceral abdominal fat in adults with HIV-associated lipodystrophy. Sermorelin is not approved for weight loss, and its effects on fat loss are not well-established. Neither peptide is a general weight-loss drug.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.